A potential role for Sirt1 in the etiology of breast cancer was postulated recently when a retrospective study found that breast cancer patients whose tumors where positive for SIRT1 via immunohistochemistry had an increased likelihood of metastasis to a distant site as well as decreased overall survival and relapse-free survival [28,29]. This evidence concerns the gene SIRT1 and breast carcinoma.